Hull University Teaching Hospital

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Fatty liver disease (MASLD/MASH)1 trial
• Obesity1 trial
• Type 2 diabetes1 trial

Phase

• Phase 21 trial
• Phase 31 trial

Status

• Active, not recruiting1 trial
• Completed1 trial

Lead sponsor

• Inventiva Pharma1 trial
• Rhythm Pharmaceuticals, Inc.1 trial

Running trials

• Active, not recruiting

  A Trial of Setmelanotide in Acquired Hypothalamic Obesity

  NCT05774756· Phase 3· Rhythm Pharmaceuticals, Inc.· Source

Closed trials

• Completed

  Placebo-controlled, Proof-of-concept Study to Evaluate the Safety and Efficacy of Lanifibranor Alone and in Combination With SGLT2 Inhibitor EmpaGliflozin in patiEnts With NASH and Type 2 Diabetes Mellitus

  NCT05232071· Phase 2· Inventiva Pharma· Source